MAPT and COVID-19: Protein markers of neuronal dysfunction including amyloid-beta, neurofilament light chain, neurogranin, total tau, and pT181-tau were all significantly increased in the nEVs of all participants recovering from COVID compared to pro-COVID-19 historical controls.